Myelodysplastic Syndromes

Showing NaN - NaN of 70

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Luspatercept
  • Epoetin Alfa
  • Concord, California
  • +100 more
Jul 20, 2023

MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +168 more
Dec 7, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +28 more
Nov 18, 2022

MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Hackensack, New Jersey
  • +6 more
Nov 18, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

MDS Trial in Tampa, Saint Louis, Seattle (CPX-351, Research skin biopsy, Research blood draw)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Tampa, Florida
  • +2 more
Apr 1, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Marina Del Rey, California
  • +35 more
Mar 11, 2022

MDS Trial in United States (Pracinostat, Azacitidine)

Terminated
  • Myelodysplastic Syndromes
  • Duarte, California
  • +24 more
Feb 4, 2022

MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)

Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Duarte, California
  • +95 more
Sep 1, 2021

Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)

Completed
  • Hematologic Malignancy
  • +4 more
  • Washington, District of Columbia
  • +12 more
Jul 20, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    MDS Trial in Worldwide (Deferasirox, Placebo)

    Completed
    • Myelodysplastic Syndromes
    • Anaheim, California
    • +71 more
    Oct 30, 2020

    Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,

    Completed
    • Acute Myeloid Leukemia
    • +12 more
    • filgrastim
    • +6 more
    • Minneapolis, Minnesota
    • +1 more
    Sep 9, 2020

    GVHD, Leukemia, MDS Trial in New Haven, Seattle (drug, radiation, other, procedure, biological)

    Terminated
    • Graft Versus Host Disease
    • +2 more
    • Fludarabine Phosphate
    • +7 more
    • New Haven, Connecticut
    • +1 more
    Aug 10, 2020

    MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • ON 01910.Na
    • Scottsdale, Arizona
    • +86 more
    Jun 29, 2020

    MDS Trial in United States (azacitidine)

    Completed
    • Myelodysplastic Syndromes
    • Bakersfield, California
    • +30 more
    Nov 7, 2019

    MDS Trial in Germany, United States (lenalidomide)

    Completed
    • Myelodysplastic Syndromes
    • Scottsdale, Arizona
    • +31 more
    Nov 6, 2019

    Acute Myeloid Leukemia, MDS, Lymphoma Trial in United States (azacitidine)

    Completed
    • Acute Myeloid Leukemia
    • +4 more
    • Greenbrae, California
    • +10 more
    Nov 6, 2019

    MDS Trial in United States (Atezolizumab, Azacitidine)

    Completed
    • Myelodysplastic Syndromes
    • Duarte, California
    • +14 more
    Aug 15, 2019

    Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in Seattle (aldesleukin)

    Completed
    • Leukemia
    • +2 more
    • aldesleukin
    • Seattle, Washington
      University of Washington Medical Center
    Feb 25, 2019

    Leukemia, Myeloid, Acute, MDS Trial in United Kingdom, United States (CC-486)

    Completed
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • New York, New York
    • +4 more
    Oct 22, 2018

    MDS Trial in Bethesda, Seattle (Metoclopramide)

    Withdrawn
    • Myelodysplastic Syndromes
    • Bethesda, Maryland
    • +1 more
    Jun 30, 2017

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Seattle (biological, drug, procedure, radiation)

    Terminated
    • Leukemia
    • +4 more
    • anti-thymocyte globulin
    • +6 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center
    May 19, 2017